Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting1
Not Yet Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06991764Not ApplicableNot Yet Recruiting

Investigating the Effectiveness of a 2-week Novel Non-invasive Brain Stimulation Technique on Cognitive Outcomes in Healthy Adults

NCT06212609Not ApplicableRecruitingPrimary

Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies

Showing all 2 trials

Research Network

Activity Timeline